Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review (vol 13, pg 1571, 2024)

被引：0
|
作者：
Blumenfeld, Andrew M. [1 ,2 ]
Mechtler, Laszlo [3 ]
Cook, Lisa [1 ]
Rhyne, Christopher [4 ]
Jenkins, Brian [5 ]
Hughes, Olivia [6 ]
Dabruzzo, Brett [7 ]
Manack Adams, Aubrey [7 ]
Diamond, Merle [8 ]
机构：
[1] Los Angeles Headache Ctr, Los Angeles, CA 90067 USA
[2] San Diego Headache Ctr, San Diego, CA 92111 USA
[3] Dent Neurol Inst, Buffalo, NY USA
[4] Norton Neurosci Inst, Louisville, KY USA
[5] Neurosci Grp, Neenah, WI USA
[6] ICON Plc, Blue Bell, PA USA
[7] AbbVie, N Chicago, IL USA
[8] Diamond Headache Clin Ltd, Chicago, IL USA
来源：
PAIN AND THERAPY | 2025年 / 14卷 / 01期
关键词：
D O I：
10.1007/s40122-024-00692-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：441 / 444
页数：4
相关论文
共 50 条
  • [1] Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Cook, Lisa
    Rhyne, Christopher
    Jenkins, Brian
    Hughes, Olivia
    Dabruzzo, Brett
    Manack Adams, Aubrey
    Diamond, Merle
    PAIN AND THERAPY, 2024, 13 (06) : 1571 - 1587
  • [2] Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
    Andrew M. Blumenfeld
    Benjamin M. Frishberg
    Jack D. Schim
    Ashley Iannone
    Gary Schneider
    Larisa Yedigarova
    Aubrey Manack Adams
    Pain and Therapy, 2021, 10 : 809 - 826
  • [3] Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
    Blumenfeld, Andrew M.
    Frishberg, Benjamin M.
    Schim, Jack D.
    Iannone, Ashley
    Schneider, Gary
    Yedigarova, Larisa
    Manack Adams, Aubrey
    PAIN AND THERAPY, 2021, 10 (02) : 809 - 826
  • [4] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Amira Salim
    Elise Hennessy
    Claire Sonneborn
    Olivia Hogue
    Sudipa Biswas
    MaryAnn Mays
    Aarushi Suneja
    Zubair Ahmed
    Ignacio F. Mata
    CNS Drugs, 2024, 38 : 481 - 491
  • [5] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Salim, Amira
    Hennessy, Elise
    Sonneborn, Claire
    Hogue, Olivia
    Biswas, Sudipa
    Mays, Maryann
    Suneja, Aarushi
    Ahmed, Zubair
    Mata, Ignacio F.
    CNS DRUGS, 2024, 38 (06) : 481 - 491
  • [6] Real-world evidence for the safety and efficacy of CGRP monoclonal antibody therapy added to OnabotulinumtoxinA treatment for migraine prevention in adult patients with chronic migraine
    Mechtler, L. L.
    Saikali, N. P.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    HEADACHE, 2021, 61 : 176 - 177
  • [7] Real-world Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients with Chronic Migraine
    Mechtler, L.
    Saikali, N.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 48 - 49
  • [8] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey
    TOXICON, 2022, 214 : S39 - S40
  • [9] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey Manack
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [10] Real-world Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients with Chronic Migraine
    Mechtler, L.
    Saikali, N.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 74 - 74
12345